期刊文献+

静脉输注舒芬太尼抑制气管拔管时咳嗽反应的临床研究

Clinical study on sufentanil infusion before extubation for supressing coughing
下载PDF
导出
摘要 目的:探讨麻醉苏醒期输注舒芬太尼对气管拔管时咳嗽反应的影响。方法81例患者随机分为3组。在术毕拔管前S1组输注舒芬太尼0.2μg/(kg·h),S2组输注舒芬太尼0.3μg/(kg·h),C组输注等容量的生理盐水。记录咳嗽分级,平均动脉压(MAP)和心率(HR),苏醒时间,术后1 h,6 h和24 h的疼痛评分,镇痛药用量,术后恶心呕吐(PONV)评分。结果与C组比较S1和S2组在拔管时咳嗽评分和MAP、HR降低;三组苏醒时间无显著差异;与控制组比较S1和S2组术后1h疼痛、PONV评分、镇痛药用量显著降低。结论拔管前舒芬太尼以(0.2~0.3)μg/(kg·h)的速率输注可抑制患者拔管时的咳嗽反应,降低镇痛药物需要量,不延长拔管时间,不增加PONV。 Objective To evaluate whether sufentanil infusion during emergence anesthesia has a effect of coughing on extubation. Methods Eighty-one patients were randomly divided into three groups. before extubation, sufentanil was administered at the group S1 at a rate of 0.2μg/(kg·h)or 0.3μg/(kg·h)at the group S2, and saline was administered to the group C. Cough score, MAP, HR and recovery profiles were recorded. The pain score, the total volume of admin-istered patient-controlled analgesia(PCA), and the postoperative nausea and vomiting(PONV) score were evaluated at 1, 6, and 24 hours after surgery. Results Compared to Group C ,Groups S1 and S2 showed significantly lower cough scores and MAP, HR on extubation. Recovery profiles showed no significant differences among the three groups. Pain score, PONV at 1 hour postoperatively, and the total volume of PCA administered at all evaluation times were signifi-cantly lower in the groups S1 and S2 than in the group C. Conclusion A sufentanil infusion(0.2~0.3)μg/(kg·h) dur-ing emergence anesthesia may suppress coughing on extubation without delaying extubation time. It may also reduce the postoperative analgesic requirement without increasing PONV.
出处 《中国现代医生》 2014年第25期60-63,共4页 China Modern Doctor
关键词 麻醉苏醒 并发症 舒芬太尼 Anesthesia recovery Complications Sufentanil
  • 相关文献

参考文献2

二级参考文献12

  • 1佘守章.新型阿片类药物在病人自控镇痛中应用研究的进展[J].临床麻醉学杂志,2006,22(11):874-877. 被引量:23
  • 2Mikawa K, Nishina K, Maekawa N, et al. Attention of Cardiovas cular responses to tracheat extubation: verapamit versus diltiazem. Anesth Analg, 1996,82 : 1205-1209.
  • 3Powell KJ,Abul-Husn NS,Jnamandas A,et al. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther, 2002,300 : 588-596.
  • 4Hahnenkamp K, Nollet J, Van Aken HK, et al. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in Xenopus laevis oocytes. Anesthesiology ,2004,100 : 1531-1537.
  • 5Albrecht S, Feehner J, Geisslinger G, et al. Postoperative pain control following remifentanil-based anesthesia for major abdominal surgery. Anaesthsia,2000,55:315-322.
  • 6Cart RM, Bernal SA. Sex differences in opioid antinociception: kappa and "mixed action" agonists. Drug Alcohol Depend ,2001, 63:215-228.
  • 7Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu- opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain ,2003,106:49-57.
  • 8Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance : intraoperative remifentauil increases postoperative pain and morphine. Anesthesiology, 2000,93 : 409 -417.
  • 9Guignard B, Coste C, Costes H, et al. Supplementing desflurane- remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth Analg,2002, 95:103-108.
  • 10Joly V, Riehebe P, Guignard B, et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology ,2005,103 : 147-155.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部